A paediatric cancer ward is a setting where pharmacists participate in direct patient care, acting as coordinators between the patient, caregivers and healthcare professionals. The aim of the study was to develop a Gap Finding Tool to support the setting up of a pharmaceutical care model at a Paediatric-Adolescent Cancer Ward.
Methods
The Standards of Practice for Clinical Pharmacy Services by the Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Clinical Pharmacy (2013), the American College of Clinical Pharmacy (2014) and the European Association of Hospital Pharmacists (2014) were used to compile the Gap Finding Tool. The developed Tool was tested for content validity by a panel of experts and subsequently implemented over 2 months.
Results
The Gap Finding Tool comprised of nine sections with an average of eight statements each about pharmacy services that should be provided at ward level. For each statement, the rater indicates whether these contributions are provided. When the Tool was implemented at the Paediatric-Adolescent Cancer Ward, four major gaps were identified, namely, absence of a clinical pharmacist, lack of medicines information, vetting of chemotherapy prescriptions by pharmacist with limited access to patient data and lack of pharmacist-input on medicines availability. Processes requiring optimisation included discharge medication advice and documentation processes.
Conclusion
The developed Gap Finding Tool is an innovative tool which is versatile and can be used in ward or ambulatory clinical settings to identify gaps in pharmaceutical processes and services and compare national or regional practices to international standards.
ErdlenbruchBLakomekMBjerreLM. Chemotherapy errors in oncology. Med Pediatr Oncol2002; 38: 353–356.
2.
LiekwegAWestfeldMJaehdeU. From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer care. Support Care Cancer2004; 12: 73–79.
3.
ViktilKBlixH. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol2008; 102: 275–280.
4.
DelpeuchALevequeDGourieuxB, et al.Impact of clinical pharmacy services in a haematology/oncology inpatient setting. Anticancer Res2015; 35: 457–460.
5.
RamadaniatiHLeeYHughesJ, et al.Pharmacists’ interventions in a paediatric haematology-oncology pharmacy: do they matter to minimise medication misadventure?Indones J Clin Pharm2016; 5: 1–10.
American College of Clinical Pharmacy. Standards of practice for clinical pharmacists. Pharmacotherapy2014; 34: 794–797.
8.
European Association of Hospital Pharmacy. The European statements of hospital pharmacy. Eur J Hosp Pharm2014; 21: 256–258.
9.
TuffahaHWAbdelhadiO. Clinical pharmacy services in the outpatient paediatric oncology clinics at a comprehensive cancer centre. Int J Clin Pharm2012; 34: 27–31.
10.
CehajicIBerganSBjordalK. Pharmacist assessment of drug-related problems on an oncology ward. Eur J Hosp Pharm2015; 22: 194–197.
11.
WalshKDoddKSeetharamanK, et al.Medication errors among adults and children with cancer in the outpatient setting. J Clin Oncol2009; 27: 891–896.
12.
HeplerCDStrandLM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm1990; 47: 533–543.
13.
HolleLMichaudL. Oncology pharmacists in health care delivery: vital members of the cancer care team. J Oncol Pract2014; 10: 142–145.
14.
LevequeDDelpeuchAGourieuxB. New anticancer agent: role of clinical pharmacy services. Anticancer Res2014; 34: 1573–1578.
15.
MaC. Role of pharmacists in optimizing the use of anticancer drugs in the clinical setting. Integr Pharm Res Pract2014; 3: 11–24.
16.
HolleLHarrisCChanA, et al.Pharmacists’ roles in oncology pharmacy services: results of a global survey. J Oncol Pharm Pract2016; 23: 185–194.
17.
FariasTAguiarKRottaI, et al.Implementing a clinical pharmacy service in haematology. Einstein (São Paulo)2016; 14: 384–390.
18.
KaboliPHothAMcClimonB, et al.Clinical pharmacists and inpatient medical care. Arch Intern Med2006; 166: 955–964.
19.
ValgusJFasoAGregoryK, et al.Integration of a clinical pharmacist into the haematology-oncology clinics at an academic medical centre. Am J Health-Syst Pharm2011; 68: 613–619.
20.
ManciniR. Implementing a standardized pharmacist assessment and evaluating the role of a pharmacist in a multidisciplinary supportive oncology clinic. J Support Oncol2012; 10: 99–106.
21.
Bhatt-MehtaVBuckMChungA, et al.Recommendations for meeting the paediatric patient's need for a clinical pharmacist: a joint opinion of the paediatrics practice and research network of the American college of clinical pharmacy and the paediatric advocacy group. J Pediatr Pharmacol Ther2012; 17: 281–291.
22.
LinQWangGMaG, et al.The role of pharmaceutical care in the oncology department. Eur J Hosp Pharm2015; 22: 128–131.
23.
KaestliLNobleSCombescureC, et al.Drug information leaflets improve parental knowledge of their child’s treatment at paediatric emergency department discharge. Eur J Hosp Pharm2015; 23: 151–155.
24.
NichollsJMacKenzieCBraundR. Preventing drug-related adverse events following hospital discharge: the role of the pharmacist. Integr Pharm Res Pract2017; 6: 61–69.
25.
YilmazMOzsoyS. Effectiveness of a discharge-planning program and home visits for meeting the physical care needs of children with cancer. Support Care Cancer2010; 18: 243–253.
26.
GandhiTBartelSShulmanL, et al.Medication safety in the ambulatory chemotherapy setting. Cancer2005; 4: 2477–2483.
27.
RodgersCStegengaKWithycombeJ, et al.Processing information after a child’s cancer diagnosis – How parents learn: a report from the children’s oncology group. J Pediatr Oncol Nurs2016; 33: 447–459.
28.
WilkinsonSCouldryR. Impacting readmission rates and patient satisfaction: results of a discharge pharmacist pilot program. Hosp Pharm2011; 46: 876–883.
29.
EilandLBennerKGumpperK, et al.ASHP-PPAGG guidelines for providing pediatric pharmacy services in hospitals and health systems. J Pediatr Pharmacol Ther2018; 23: 177–191.
30.
NguyenVAltares SarikDDejosM, et al.Development of an interprofessional pharmacist-nurse navigation pediatric discharge program. J Pediatr Pharmacol Ther2018; 23: 320–328.
31.
ShullMBraitmanLStitesS, et al.Effects of a pharmacist-driven intervention program of hospital readmissions. Am J Health-Syst Pharm2018; 75: e221–e230.
32.
BalakrishnanRRavichandranRDillibatchaJ, et al.Clinical pharmacists’ role in paediatric patients’ medical care. Int J Contemp Pediatr2020; 7: 2416–2420.
33.
GlickAFarkasJNicholsonJ, et al.Parental management of discharge instructions: a systematic review. Pediatrics2017; 140: e20164165.
34.
HorstmanMMillsWHermanL, et al.Patient experience with discharge instructions in post discharge recovery: a qualitative study. BMJ Open2017; 7: e014842.
35.
KempKSantanaMJolleyR, et al.Discharge communication and patient involvement are associated with unplanned hospital readmissions: results from a validated hospital experience survey. Int J Popul Data Sci2017; 1(1). doi: 10.23889/ijpds.v1i1.87.
36.
ThomasDBradleyLServiA, et al.Parental knowledge and recall of concussion discharge instructions. J Emerg Nurs2018; 44: 52–56.
37.
DiPiroJTalbertRYeeG,et al.Pharmacotherapy: a pathophysiologic approach. 8th ed. New York: McGraw-Hill Education, 2011.
38.
StrandLCipolleRMorleyP. Documenting the clinical pharmacist activities: back to basics. Drug Intell Clin Pharm1988; 22: 63–67.
39.
FoxBFelkeyBBergerB, et al.Use of personal digital assistants for documentation of pharmacist’s interventions: a literature review. Am J Health-Syst Pharm2007; 64: 1516–1525.
40.
Zierler-BrownSBrownTRChenD, et al.Clinical documentation for patient care: models, concepts and liability considerations for pharmacists. Am J Health-Syst Pharm2007; 64: 1851–1858.
41.
HutchinsonLCCastleberryA. The pharmacist’s new role as part of an interdisciplinary care team. Generations2011; 35: 62–68.
42.
MamoMWirthFAzzopardi L,et al.Standardising pharmacist patient-profiling activities in a rehabilitation hospital in Malta. Eur J Hosp Pharm2013; 21: 49–53.
